Biosimilars Action Plan

FDA is committed to encouraging innovation and competition for biologics and facilitating the development of safe and effective biosimilars.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news